Learn more

AVANIR PHARMACEUTICALS

Overview
  • Total Patents
    352
  • GoodIP Patent Rank
    183,497
  • Filing trend
    0.0%
About

AVANIR PHARMACEUTICALS has a total of 352 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 1990. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BAYER PHARMA AKTIENGELLSCHAFT, MEI PHARMA INC and BAYER SHERING PHARMA AG.

Patent filings per year

Chart showing AVANIR PHARMACEUTICALSs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Sircar Jagadish C 119
#2 Sircar Jagadish 105
#3 Richards Mark L 87
#4 Ying Wenbin 71
#5 Pope Laura E 62
#6 Nikoulin Igor 46
#7 Major Michael W 43
#8 Katz David H 40
#9 Khalil Mohammed H 40
#10 Marcelletti John F 38

Latest patents

Publication Filing date Title
ZA200807481B Pharmaceutical compositions for treating depression, anxiety and neurodegenerative disorders
WO2009006194A1 Pharmaceutical compositions for the treatment of involuntary emotional expression disorder
WO2008116118A2 Fully human antibodies to gram positive bacteria
WO2008097924A2 Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders
WO2008008841A2 Use of benzimidazole derivatives for the treatment and/or prevention of autoimmune disorders
AU2007201494A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AU2007212586A1 Pharmaceutical compositions for treating depression, anxiety and neurodegenerative disorders
WO2007055873A2 Process for the manufacture of peptide facilitators of reverse cholesterol transport
CN101189240A Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
AU2006227297A1 Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
EP1753782A1 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
EP1753724A1 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases
CN1984928A Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
EP1753733A1 Small molecules for treatment of hypercholesterolemia and related diseases
WO2006049597A1 Amino acid-derived compounds as modulators of the reverse cholesterol transport
AU2004263190A1 Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
EP1656376A1 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
CN1809590A Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
EP1613310A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders
MY142846A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same